• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾癌的肿瘤内异质性。

Intratumoral heterogeneity in kidney cancer.

机构信息

Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA.

出版信息

Nat Genet. 2014 Mar;46(3):214-5. doi: 10.1038/ng.2904.

DOI:10.1038/ng.2904
PMID:24569233
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4193312/
Abstract

Clear cell renal cell carcinoma (CCRCC) is characterized by mutation of the VHL gene and loss of a segment of chromosome 3. A new study using multi-region exome sequencing has identified substantial intratumoral heterogeneity within large primary CCRCCs, which has profound implications for understanding tumor evolution and for developing effective therapies.

摘要

透明细胞肾细胞癌(CCRCC)的特征是 VHL 基因突变和 3 号染色体部分缺失。一项新的使用多区域外显子组测序的研究表明,大型原发性 CCRCC 内存在大量肿瘤内异质性,这对理解肿瘤进化和开发有效疗法具有深远意义。

相似文献

1
Intratumoral heterogeneity in kidney cancer.肾癌的肿瘤内异质性。
Nat Genet. 2014 Mar;46(3):214-5. doi: 10.1038/ng.2904.
2
Improved identification of von Hippel-Lindau gene alterations in clear cell renal tumors.透明细胞肾肿瘤中冯·希佩尔-林道基因改变的识别得到改善。
Clin Cancer Res. 2008 Aug 1;14(15):4726-34. doi: 10.1158/1078-0432.CCR-07-4921.
3
[The expression of hypoxia inducible factor-1,2 alpha in sporadic clear cell renal cell carcinoma and their relationships to the mutations of von Hippel-Lindau gene].[缺氧诱导因子-1、2α在散发性透明细胞肾细胞癌中的表达及其与冯·希佩尔-林道基因变异的关系]
Zhonghua Wai Ke Za Zhi. 2005 Mar 15;43(6):390-3.
4
von-Hippel Lindau and Hypoxia-Inducible Factor at the Center of Renal Cell Carcinoma Biology.von Hippel-Lindau 与缺氧诱导因子在肾细胞癌生物学中的核心地位。
Hematol Oncol Clin North Am. 2023 Oct;37(5):809-825. doi: 10.1016/j.hoc.2023.04.011. Epub 2023 Jun 1.
5
The von Hippel-Lindau tumor suppressor protein regulates gene expression and tumor growth through histone demethylase JARID1C.von Hippel-Lindau 肿瘤抑制蛋白通过组蛋白去甲基酶 JARID1C 调节基因表达和肿瘤生长。
Oncogene. 2012 Feb 9;31(6):776-86. doi: 10.1038/onc.2011.266. Epub 2011 Jul 4.
6
Renal Cell Carcinoma Programmed Death-ligand 1, a New Direct Target of Hypoxia-inducible Factor-2 Alpha, is Regulated by von Hippel-Lindau Gene Mutation Status.肾透明细胞癌程序性死亡配体 1 是缺氧诱导因子-2α的新的直接靶标,受 von Hippel-Lindau 基因突变状态调控。
Eur Urol. 2016 Oct;70(4):623-632. doi: 10.1016/j.eururo.2015.11.029. Epub 2015 Dec 23.
7
[Tumor suppressor gene VHL, hypoxia inducible factor, and renal cell carcinoma].[肿瘤抑制基因VHL、缺氧诱导因子与肾细胞癌]
Zhonghua Bing Li Xue Za Zhi. 2006 Sep;35(9):562-4.
8
Tuberous sclerosis complex protein 1 expression is affected by VHL Gene alterations and HIF-1α production in sporadic clear-cell renal cell carcinoma.结节性硬化症复合物蛋白1的表达受散发性透明细胞肾细胞癌中VHL基因改变和HIF-1α产生的影响。
Exp Mol Pathol. 2016 Dec;101(3):323-331. doi: 10.1016/j.yexmp.2016.11.003. Epub 2016 Nov 12.
9
Molecular genetics of clear-cell renal cell carcinoma.透明细胞肾细胞癌的分子遗传学
J Clin Oncol. 2014 Jun 20;32(18):1968-76. doi: 10.1200/JCO.2012.45.2003. Epub 2014 May 12.
10
Hypoxia, Hypoxia-inducible Transcription Factors, and Renal Cancer.缺氧、缺氧诱导转录因子与肾癌
Eur Urol. 2016 Apr;69(4):646-657. doi: 10.1016/j.eururo.2015.08.007. Epub 2015 Aug 19.

引用本文的文献

1
Adaptations of lipid metabolism in low-grade clear cell renal cell carcinoma are linked to cholesteryl ester accumulation.低级别透明细胞肾细胞癌中脂质代谢的适应性变化与胆固醇酯积累有关。
Sci Rep. 2025 Jul 9;15(1):24762. doi: 10.1038/s41598-025-09664-x.
2
NDUFA4L2 reduces mitochondrial respiration resulting in defective lysosomal trafficking in clear cell renal cell carcinoma.NDUFA4L2可降低线粒体呼吸作用,导致透明细胞肾细胞癌中的溶酶体运输功能缺陷。
Cancer Biol Ther. 2023 Dec 31;24(1):2170669. doi: 10.1080/15384047.2023.2170669.
3
Locus-Specific Bisulfate NGS Sequencing of GSTP1, RNF219, and KIAA1539 Genes in the Total Pool of Cell-Free and Cell-Surface-Bound DNA in Prostate Cancer: A Novel Approach for Prostate Cancer Diagnostics.

本文引用的文献

1
Integrated molecular analysis of clear-cell renal cell carcinoma.透明细胞肾细胞癌的综合分子分析。
Nat Genet. 2013 Aug;45(8):860-7. doi: 10.1038/ng.2699. Epub 2013 Jun 24.
2
Comprehensive molecular characterization of clear cell renal cell carcinoma.透明细胞肾细胞癌的全面分子特征分析。
Nature. 2013 Jul 4;499(7456):43-9. doi: 10.1038/nature12222. Epub 2013 Jun 23.
3
Distinct evolutionary trajectories of primary high-grade serous ovarian cancers revealed through spatial mutational profiling.通过空间突变分析揭示原发性高级别浆液性卵巢癌的独特进化轨迹。
前列腺癌游离和细胞表面结合DNA总库中GSTP1、RNF219和KIAA1539基因的位点特异性亚硫酸氢盐NGS测序:一种前列腺癌诊断的新方法
Cancers (Basel). 2023 Jan 9;15(2):431. doi: 10.3390/cancers15020431.
4
In Silico Investigations of Multi-Drug Adaptive Therapy Protocols.多药适应性治疗方案的计算机模拟研究
Cancers (Basel). 2022 May 30;14(11):2699. doi: 10.3390/cancers14112699.
5
Mitochondrial Ndufa4l2 Enhances Deposition of Lipids and Expression of Ca9 in the TRACK Model of Early Clear Cell Renal Cell Carcinoma.线粒体Ndufa4l2在早期透明细胞肾细胞癌的TRACK模型中增强脂质沉积和Ca9表达。
Front Oncol. 2021 Dec 14;11:783856. doi: 10.3389/fonc.2021.783856. eCollection 2021.
6
Locus-Specific Methylation of GSTP1, RNF219, and KIAA1539 Genes with Single Molecule Resolution in Cell-Free DNA from Healthy Donors and Prostate Tumor Patients: Application in Diagnostics.健康供体和前列腺肿瘤患者游离DNA中GSTP1、RNF219和KIAA1539基因位点特异性甲基化的单分子分辨率研究:在诊断中的应用
Cancers (Basel). 2021 Dec 12;13(24):6234. doi: 10.3390/cancers13246234.
7
Comparison of cortico-medullary phase contrast-enhanced MDCT and T2-weighted MR imaging in the histological subtype differentiation of renal cell carcinoma: radiology-pathology correlation.皮质髓质期对比增强MDCT与T2加权MRI成像在肾细胞癌组织学亚型鉴别中的比较:放射学与病理学相关性
Pol J Radiol. 2021 Oct 15;86:e583-e593. doi: 10.5114/pjr.2021.111013. eCollection 2021.
8
Resource-efficient pooled sequencing expands translational impact in solid tumors.资源高效的混合测序扩大了在实体瘤中的转化影响。
Kidney Cancer J. 2021 Jun;19(2):18-23. doi: 10.52733/KCJ18n2.a1. Epub 2021 Jun 24.
9
Adoptive cellular therapy in solid tumor malignancies: review of the literature and challenges ahead.实体瘤恶性肿瘤的过继细胞疗法:文献回顾与未来挑战。
J Immunother Cancer. 2021 Jul;9(7). doi: 10.1136/jitc-2021-002723.
10
The Hypoxic Microenvironment Induces Stearoyl-CoA Desaturase-1 Overexpression and Lipidomic Profile Changes in Clear Cell Renal Cell Carcinoma.缺氧微环境诱导透明细胞肾细胞癌中硬脂酰辅酶A去饱和酶-1过表达及脂质组学特征改变
Cancers (Basel). 2021 Jun 13;13(12):2962. doi: 10.3390/cancers13122962.
J Pathol. 2013 Sep;231(1):21-34. doi: 10.1002/path.4230.
4
Adverse outcomes in clear cell renal cell carcinoma with mutations of 3p21 epigenetic regulators BAP1 and SETD2: a report by MSKCC and the KIRC TCGA research network.3p21 组蛋白修饰基因 BAP1 和 SETD2 突变的肾透明细胞癌不良预后:来自 MSKCC 和 KIRC TCGA 研究网络的报告。
Clin Cancer Res. 2013 Jun 15;19(12):3259-67. doi: 10.1158/1078-0432.CCR-12-3886. Epub 2013 Apr 25.
5
Genetic basis of kidney cancer: role of genomics for the development of disease-based therapeutics.肾癌的遗传学基础:基因组学在基于疾病的治疗开发中的作用。
Genome Res. 2012 Nov;22(11):2089-100. doi: 10.1101/gr.131110.111. Epub 2012 Oct 4.
6
Intratumor heterogeneity: seeing the wood for the trees.肿瘤内异质性:只见树木,不见森林。
Sci Transl Med. 2012 Mar 28;4(127):127ps10. doi: 10.1126/scitranslmed.3003854.
7
Intratumor heterogeneity and branched evolution revealed by multiregion sequencing.多区域测序揭示的肿瘤内异质性和分支进化。
N Engl J Med. 2012 Mar 8;366(10):883-892. doi: 10.1056/NEJMoa1113205.
8
Tumour evolution inferred by single-cell sequencing.单细胞测序推断肿瘤进化。
Nature. 2011 Apr 7;472(7341):90-4. doi: 10.1038/nature09807. Epub 2011 Mar 13.
9
Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma.外显子组测序鉴定出肾癌中 SWI/SNF 复合物基因 PBRM1 的高频突变。
Nature. 2011 Jan 27;469(7331):539-42. doi: 10.1038/nature09639. Epub 2011 Jan 19.
10
The patterns and dynamics of genomic instability in metastatic pancreatic cancer.转移性胰腺癌中基因组不稳定性的模式和动态。
Nature. 2010 Oct 28;467(7319):1109-13. doi: 10.1038/nature09460.